Sterling Capital Management’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-198	Closed	-$402	–	3266
2025 Q1	$402	Sell	198 -203	-51%	-$412	﹤0.01%	2999
2024 Q4	$2.41K	Buy	401 +364	+984%	+$2.19K	﹤0.01%	2732
2024 Q3	$259	Buy	+37	New	+$259	﹤0.01%	3069